A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors

NCT00756340 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Recurrent or Refractory Solid Tumors
CNS Malignancies

Interventions

DRUG: Bevacizumab
DRUG: Everolimus

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]